Incorporating biomarkers of frailty and senescence in cancer therapeutic trials.
about
Mortality in Relation to Frailty in Patients Admitted to a Specialized Geriatric Intensive Care Unit.How should older adults with cancer be evaluated for frailty?Aging: Treating the Older Patient.ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial and health cost outcomeS (GERAS): protocol of a nationwide prospective cohort study.Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myelomaAcute Sarcopenia Secondary to Hospitalisation - An Emerging Condition Affecting Older Adults.
P2860
Incorporating biomarkers of frailty and senescence in cancer therapeutic trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Incorporating biomarkers of frailty and senescence in cancer therapeutic trials.
@en
type
label
Incorporating biomarkers of frailty and senescence in cancer therapeutic trials.
@en
prefLabel
Incorporating biomarkers of frailty and senescence in cancer therapeutic trials.
@en
P2860
P356
P1476
Incorporating biomarkers of frailty and senescence in cancer therapeutic trials.
@en
P2093
Aminah Jatoi
Joleen M Hubbard
P2860
P304
P356
10.1093/GERONA/GLU046
P407
P577
2014-04-26T00:00:00Z